Sumitomo Chemical Europe / N.V. is a CMO/CDMO company operating in the pharmaceutical industry.
Sumitomo Chemical is since more than four decades a leading CMO, offering high quality raw materials, regulatory starting materials, GMP intermediates, and API. Due to strong demand for its products and services, Sumitomo Chemical keeps investing in additional commercial scale manufacturing capacity and will bring on stream a new oligonucleotides manufacturing plant in June 2023 and a new small molecules plant, both at its Oita Works site, Japan, in respectively June 2023 and September 2024.
Company type
CMO/CDMO
Products and services
Custom Manufacturing, APIs (Active Pharmaceutical Ingredients)
Markets
North America (USA, Canada), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South East Asia (e.g. Thailand, Philippines, Singapore)
Useful Links
Connect with Sumitomo Chemical Europe / N.V. on LinkedIn
Address
Sumitomo Chemical Europe / N.V., Woluwelaan, 57, Machelen, Belgium, B-1830
